RxDoctor Payments Data

Melanie Dispenza

Allergy & Immunology · Baltimore, MDNPI 1942543541

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,650 of the $19,587 with a category attached, or 74.8%. 6 manufacturers reported payments, led by Blueprint Medicines Corporation at 50.8% of the total. 2025 is the largest year on record at $8,127, 3.7 times the $2,226 reported in 2022. Among allergy & immunology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,587in general payments, 2019–2025

Across 18 payments — averaging $1088.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Blueprint Medicines Corporation$10K
  • Novartis$7K
  • Melinta Therapeutics, LLC$2K
  • Alk-abello, Inc$1K
  • Grifols USA, LLC$146
  • Sanofi$37
$846,040in research payments, 2019–2025

Across 2 payments — averaging $423,020 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$846K

What the payments were for

  • Consulting fees$14,65075%
  • Speaking & faculty fees$4,29322%
  • Travel & lodging$370%
  • Food & beverage$6073%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,587 in reported general payments places this provider in the 90th percentile of 105 allergy & immunology providers in Maryland.

See all allergy & immunology providers in Maryland

Medicare billing

Part B allowed, 2024
$6,672
Medicare patients
32
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →